Serum xylosyltransferase: A new biochemical marker of the sclerotic process in systemic sclerosis

Journal of Investigative Dermatology

Volumn 112, Issue 6, 1999, Pages 919-924

  Götting, Christian ^b   Sollberg, Stephan ^a   Kuhn, Joachim ^b   Weilke, Christian ^b   Huerkamp, Christina ^a   Brinkmann, Thomas ^b   Krieg, Thomas ^a   Kleesick, Knut ^b,c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Chondroitin sulfate proteoglycan; Systemic sclerosis; Xylosyltransferase

Indexed keywords

BIOCHEMICAL MARKER; COLCHICINE; DERMATAN SULFATE; PROTEOCHONDROITIN SULFATE; TRANSFERASE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE XYLOSE; XYLOSYLTRANSFERASE;

ADULT; AGED; ARTICLE; CARTILAGE CELL; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; SCLERODERMA; SKIN FIBROBLAST; SYSTEMIC SCLEROSIS;

EID: 0033002705     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00590.x     Document Type: Article

References (35)

1. Akimoto S, Hayashi H, Ishikawa H: Disaccharide analysis of the skin glycosaminoglycans in systemic sclerosis. Br J Dermatol 126:29-34, 1992
2. Bashey RI, Millan A, Jimenez SA: Increased biosynthesis of glycosaminoglycans by scleroderma fibroblasts in culture. Arthritis Rheum 27:1040-1045, 1984
3. Brinkmann T, Weilke C, Kleesick K: Recognition of acceptor proteins by UDP-D-xylose proteoglycan core protein β-D-xylosyltransferase. J Biol Chem 272:11171-11175, 1997
4. Butler M, Dawson M: Cell Culture Labfax. Oxford: Bios Scientific Publishers, 1992
5. Cabral A, Castor CW: Connective tissue activation XXVII. The behavior of skin fibroblasts from patients with scleroderma. Arthritis Rheum 26:1362-1369, 1983
6. Evangelisti R, Becchetti E, Baroni T, et al: Modulation of phenotypic expression of fibroblasts by alteration of the cytoskeleton. Cell Biochem Funct 13:41-52, 1995
7. Fleischmajer R, Perlish JS: Glycosaminoglycans in scleroderma and scleredema. J Invest Dermatol 58:129-132, 1972
8. Glössl J, Beck M, Kresse H: Biosynthesis of proteodermatan sulfate in cultured human fibroblasts. J Biol Chem 259:14144-14150, 1984
9. Higushi T, Ohnishi K, Hayashi H, Ishikawa O, Miyachi Y: Changes in skin disaccharide components correlate with the severity of sclerotic skin in systemic sclerosis. Acta Derm: Venereol (Stockh) 74:179-182, 1994
10. Hoffmann HP, Schwartz NB, Rodén L, Prockop DJ: Location of xylosyltransferase in the cisternae of the rough endoplasmic reticulum of embryonic chick cartilage cells. Connect Tissue Res 12:151-164, 1984
11. Ishikawa H, Horiuchi R: Initial change of glycosaminoglycans in systemic scleroderma. Dermatologica 150:334-345, 1975
12. Juhlin J, Tengblad A, Ortonne JP, Lacour JPH: Hyaluronate in suction blisters from patients with scleroderma and various skin disorders. Acta Derm Venereol (Stockh) 66:409-413, 1986
13. Kähnen H, Paddenberg R, Kleesiek K: Simultaneous secretion of xylosyltransferase and chondroitin sulphate proteoglycan in chondrocyte culture. Eur J Clin Chem Clin Biochem 29:624-625, 1991
14. Kähnert H, Brinkmann T, Gässler N, Kleesiek K: Determination of chondroitin-6-sulphate by a competitive enzyme immunoassay using a biotinylated antigen. Eur J Clin Chem Clin Biochem 32:293-299, 1994
15. Keams AE, Campbell SC, Westley J, Schwartz NB: Initiation of chondroitin sulfate biosynthesis: a kinetic analysis of UDP-D-xylose: core protein β-D-xylosyltransferase. Biochemistry 30:7477-7483, 1991
16. 4 by monolayer cultures of chick embryo chondrocytes. J Biol Chem 255:1586-1597, 1980
17. Kitabatake M, Ishikawa H, Maeda H: Immunohistochemical demonstration of proteoglycans in the skin of patients with systemic sclerosis. Br J Dermatol 108:257-262, 1983
18. Kjellen L, Lindahl U: Proteoglycans: structures and interactions. Annu Rev Biochem 60:443-475, 1991
19. Kleesiek K, Reinards R, Okusi J, Wolf B, Greiling H: UDP-D-xylose: proteoglycan core protein β-D-xylosyltransferase: a new marker of cartilage destruction in chronic joint diseases. J Clin Chem Biochem 25:473-481, 1987
20. Kresse H, Hausser H, Schönherr E, Bittner K: Biosynthesis and interactions of small chondroitin/dermatan sulphate proteoglycans. Eur J Clin Chem Clin Biochem 32:259-264, 1994
21. Krieg T, Meurer M: Systemic scleroderma. Clinical and pathophysiologic aspects. J Am Acad Dermatol 18:457-479, 1988
22. LeRoy EC: Increased collagen synthesis by scleroderma skin fibroblasts in vitro. A possible defect in the regulation or activation by scleroderma fibroblasts. J Clin Invest 54:880-889, 1974
23. LeRoy EC: Black C, Fleishmayer R, et al: Scleroderma (systemic sclerosis). Classification, subsets and pathogenesis. J Rheumatol 15:202-205, 1988
24. Maeda H, Ishikawa H, Ohta S: Circumscribed myxoedematosus as a sign of faulty formation of the proteoglycan macromolecule. Br J Dermatol 105:239-245, 1981
25. Perez MI, Kohn SR: Systemic sclerosis. J Am Acad Dermatol 28:525-547, 1993
26. Rennison ME, Handel SE, Wilde CJ, Burgoyne RD: Investigation of the role of microtubules in protein secretion from lactating mouse mammary epithelial cells. J Cell Sci 102:239-247, 1992
27. Rodén L. Structure and metabolism of connective tissue proteoglycans. In: Lennarz WJ (ed,) The Biochemistry of Glycoproteins and Proteoglycans. New York: Plenum Publishers, 1980, 269-314
28. Schmidt G, Robenek H, Harrach B, et al: Interaction of small dermatan sulfate protcoglycans from fibroblasts with fibronectin. J Cell Biol 104:1683-1691, 1987
29. Schwartz NB: Regulation of chondroitin sulfate synthesis. Effect of β-xylosides on synthesis of chondroitin sulfate proteoglycan, chondroitin sulfate chains, and core protein. J Biol Chem 252:6316-6321, 1977
30. Silman A, Harrison M, Brennan P: Is it possible to reduce observer variability in skin score assessment of scleroderma ? J Rheumatol 22:1277-1280, 1995
31. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590, 1980
32. Tajima S, Nishikawa T, Hatano H, Nagai Y: Distribution of glycosaminoglycans in dermal connective tissue from scleroderma patients. J Dermatol 9:405-408, 1982
33. Vogel KG, Paulsson M, Heinegard D: Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 223:587-597, 1984
34. Vogel KG, Trotter JA: The effect of proteoglycans on the morphology of collagen fibrils formed in vitro. Collagen Red Res 7:105-114, 1987
35. Weilke C, Brinkmann T, Kleesiek K: Determination of xylosyltransferase activity in serum with recombinant human bikunin as acceptor. Clin Chem 43:45-51, 1997